Swil-NewsWED · SEP 23 · 2026 · ISSUE № 2026.09.23
Same-day topicsGeneralFinance & marketsAI & techScience & researchCrypto & Web3Energy & climateAuto & mobilityGaming & entertainmentSupply chain & manufacturingSports, health & nutritionCurrent
Back to Sports, health & nutritionBack to home

Sep 23, 2026 · Sports, Health & Nutrition Daily Digest

A roundup of sports, fitness, wellness, and nutrition news for Sep 23, 2026, with summaries, links, and commentary.


I. Nutrition & Diet

1. Dose–response meta-analysis: each extra 100 g/day of ultra-processed food tied to ~14% higher cardiovascular-event risk (Nutrition)

Summary:

A dose–response meta-analysis in Family Medicine and Community Health (DOI: 10.1136/fmch-2026-003925; Medical Xpress / Medical News Today, Sep 23, 2026) pooled 51 prospective cohorts searched through April 2026—about 8.82 million adults across the Americas, Europe, Asia, and Oceania (mean ages ~23–77; follow-up 2–32 years). Higher ultra-processed food (UPF) intake was associated with greater risks of cardiovascular events, cancer, overweight/obesity, metabolic syndrome/diabetes, depression/anxiety, digestive disease, hypertension, and all-cause death (high-intake relative increases roughly in the 11%–31% range across outcomes). Each additional ~100 g/day of UPF was linked to about 14% higher cardiovascular-event risk, 4% higher cancer risk, 3% higher all-cause mortality, and 2% higher metabolic syndrome/diabetes risk; each 10% rise in weight/energy share was tied to ~16% higher metabolic syndrome/diabetes risk. This is observational synthesis based on self-reported diet and cannot prove that processing itself is causal or fully separate broader lifestyle patterns.

Links:

Commentary:

You need not chase zero UPFs, but swapping packaged snacks, sweet drinks, processed meats, and ready meals for vegetables, legumes, whole grains, and home cooking remains the most evidence-aligned default.


2. JAMA Psychiatry pilot: cutting UPFs by >85% linked to moderate-to-large depression symptom gains (Nutrition / Mental health)

Summary:

A UCSF team reported a crossover pilot in JAMA Psychiatry (Sep 23, 2026; NIH-funded; UCSF / EurekAlert same day). Twenty adults with major depression (mean age ~44; 70% female; most also had anxiety, high BMI, and at least one metabolic condition) were randomized to keep their usual diet or shift to a low-UPF diet for four weeks, then crossed over; the low-UPF phase used researcher-guided self-shopping. UPF intake fell by more than 85%, with moderate-to-large improvements on three depression measures and modest anxiety gains. Authors stress the small sample mainly proved feasibility for a larger trial (phase II enrollment expected around 2028); gut-barrier/inflammation hypotheses were not proven here.

Links:

Commentary:

Keep guideline mental-health care first; if your diet is heavily ultra-processed, a gradual, clinician-aware shift toward less-processed meals can be an adjunct—not a substitute for medication or psychotherapy.


3. Circulation: higher adherence to eight healthy post-MI diet patterns linked to lower long-term mortality (Nutrition)

Summary:

Working with Harvard nutrition researchers, Xi’an Jiaotong University’s Le Ma and colleagues analyzed 3,277 women and 2,618 men who survived nonfatal MI in the Nurses’ Health Study and Health Professionals Follow-Up Study (mean age at diagnosis ~68.2 years), published in Circulation (XJTU news Sep 23, 2026; PubMed PMID: 42639679). Validated FFQs updated every 2–4 years scored post-MI adherence to eight healthy patterns (AHEI, HEI-2015, alternate Mediterranean, DASH, healthful plant-based index, and three reversed empirical inflammation/insulin scores). Over ~15.7 years, 3,858 deaths occurred. Highest vs lowest quintiles showed all-cause mortality HRs roughly 0.66–0.77 across patterns, with similar inverse signals for CVD death and recurrent nonfatal MI. Improving AHEI from pre- to post-MI was associated with HR ~0.86 (~14% lower mortality); declining adherence tracked worse prognosis. Observational residual confounding remains possible.

Links:

Commentary:

After a heart attack, stop hunting one “perfect” diet; use cardiac rehab as a window to lock in vegetables, whole grains, legumes, nuts, fish, and fewer processed meats and sugary drinks.


4. Childhood Obesity: ~1 in 6 U.S. children on GLP-1s diagnosed with a nutritional deficiency within a year (Nutrition / Public health)

Summary:

Ryder and colleagues at Lurie Children’s used 2017–2022 U.S. claims covering >100 million patients to identify 2,031 GLP-1 users aged 10–17 with no prior deficiency diagnosis (Childhood Obesity, DOI: 10.1177/21532176261486979; institutional release ~Sep 21, widely covered through Sep 23). Within one year, ~16.8% had at least one nutritional deficiency or related complication (~10.2% by 180 days); vitamin D deficiency ~12.4% and nutritional anemia ~1.55%. Most common agents were liraglutide (~78.6%), dulaglutide (~10.4%), and semaglutide (~9.1%). Only ~5% received nutrition counseling within 30 days and under 25% within six months. Claims capture coded diagnoses, not proven drug causation, and may reflect testing intensity.

Links:

Commentary:

Pair adolescent GLP-1 care with nutrition follow-up (protein, iron, vitamin D, calcium, resistance training)—do not prescribe and walk away; flag sudden appetite collapse, fatigue, or pallor for review.


II. Exercise & Training Science

5. JISSN: 10 g/day creatine for 12 weeks raised lean tissue and strength in adults 45–65—even without structured training (Training / Supplements)

Summary:

Kreider et al. (Texas A&M) reported a 12-week double-blind trial in the Journal of the International Society of Sports Nutrition (DOI: 10.1080/15502783.2026.2716273; Texas A&M / Futurity coverage circulating Sep 23). Seventy-three sedentary healthy adults chose whether to join structured exercise plus mild calorie restriction, then were randomized to 10 g/day creatine monohydrate or maltodextrin placebo; 64 completers aged 45–65 were analyzed. Without exercise, creatine added ~1.1 kg (~2.4 lb) of DXA lean tissue and improved leg-press and bench-press strength/endurance; with exercise plus energy restriction, creatine further increased lean tissue, lowered body-fat percentage more than placebo, and improved strength and time to exhaustion. Supplementation was generally well tolerated. Commentators note DXA lean mass includes water, so gains are not pure new muscle fiber; the dose exceeds typical 3–5 g/day maintenance.

Links:

Commentary:

Creatine remains one of the better-supported supplements, but training plus adequate protein stay primary for midlife adults; check with a clinician if you have kidney disease, and do not treat powder as a gym substitute.


6. European Geriatric Medicine: 12 weeks of resistance training boosts function in older adults while muscle and body-composition domains lag (Training)

Summary:

Matko, Grote and colleagues followed 126 healthy older adults through 12 weeks of supervised resistance-based training in European Geriatric Medicine (DOI: 10.1007/s41999-026-01614-8; Scienmag Sep 23, 2026), scoring four domains separately: functional performance, muscle capacity, body composition, and pain/health-related quality of life. Function improved strongly (standardized effect ~0.67; ~80% improved); muscle capacity was largely flat, body composition shifted slightly unfavorably, and pain/QoL responses split almost evenly between better and worse. Baseline Timed Up and Go averaged ~6.1 seconds—already fast—possibly limiting “strength” upside. About 46% met an exploratory responder threshold; authors propose a multidomain non-responder framework rather than a single endpoint. Reporting is within a supervised intervention cohort; extrapolation to frail older adults needs caution.

Links:

Commentary:

If the scale or tape measure barely budges, check sit-to-stand, walking, and stair ease first; worsening pain or QoL means adjust load and recovery—not abandon resistance training.


III. Sleep & Mental Health

7. Non-inferiority RCT: dietitian- and exercise physiologist–led lifestyle therapy not inferior to brief CBT for depression (Mental health)

Summary:

O’Neil and colleagues at Deakin University ran a remote, single-blind, non-inferiority RCT (New Scientist Sep 23, 2026; Sciety preprint abstract). Adults with moderate-to-severe major depression or bipolar depression (n=358 randomized) received lifestyle therapy (accredited dietitians and exercise physiologists: mindful eating, enjoyable activity, alcohol management, sleep) or brief structured CBT over ~eight weeks. Primary outcome was blinded MADRS at week 8 with a −1.6-point non-inferiority margin; 267 participants had primary data. MADRS fell ~8.55 points with lifestyle therapy vs ~6.82 with CBT; ITT and per-protocol analyses supported non-inferiority, with self-reported gains sustained at 16 and 24 weeks. Authors argue this could expand the first-line workforce. Severe mood disorders still need psychiatric oversight; the trial does not mean everyone can self-replace therapy with DIY “eat-move-sleep.”

Links:

Commentary:

Structured diet, exercise, and sleep coaching can sit on the formal depression-care menu—especially when psychotherapy waitlists are long—but acute self-harm risk still belongs in emergency/psychiatric pathways.


8. Lancet Healthy Longevity: CBT-I vs sleep education in older insomnia—higher remission and slower DunedinPACE (Sleep)

Summary:

UCLA investigators published a secondary analysis of a prior RCT in adults ≥60 with DSM-IV insomnia in The Lancet Healthy Longevity (UCLA Health release; Medical News Today coverage). Participants with paired epigenetic data (CBT-I n=47; sleep education therapy/SET n=45) gave blood at baseline and ~20–39 months later for DunedinPACE, GrimAge, and PCPhenoAge. Full remission was ~34% after CBT-I vs ~13% after SET; vs SET, CBT-I showed slower DunedinPACE (about −0.02; FDR p=0.03), while GrimAge and PCPhenoAge between-group differences were not significant. This is a small, single-site secondary analysis and does not prove CBT-I extends lifespan or prevents age-related disease.

Links:

Commentary:

For chronic insomnia, prioritize CBT-I (including digital/group formats) over stacking sleep aids or “anti-aging” supplements; epigenetic clocks remain research tools, not home targets.


IV. Public Health & Disease Prevention

9. Lancet journal: ~44% steatotic liver disease and ~4.4% fibrosis signals in Chinese community adults (Public health)

Summary:

The CHESS-LiverHealth baseline, led by Qi Xiaolong and Teng Gaojun (Zhongda Hospital, Southeast University), appears in The Lancet Gastroenterology & Hepatology (DOI: 10.1016/S2468-1253(26)00224-4; Chinese press Sep 23, 2026). Vibration-controlled transient elastography in 25,736 community adults across 13 provincial regions (median age ~51) found LSM ≥8 kPa in ~4.4%, ≥10 kPa in ~1.6%, and ≥12 kPa in ~0.8%; steatotic liver disease in ~43.7% (MASLD ~39.5%, MetALD ~2.0%, ALD ~1.6%). Fibrosis prevalence reached ~10.7% in both obesity and type 2 diabetes. Male sex, older age, overweight/obesity, central obesity, dysglycemia, hypertension, dyslipidemia, heavy drinking, and chronic viral hepatitis were independently associated. Cross-sectional baselines do not replace individual clinical diagnosis.

Links:

Commentary:

“No liver pain” is not clearance; if you have obesity, diabetes, hypertension, or heavy alcohol use, ask about elastography/steatosis screening and treat weight, glucose, lipids, blood pressure, and alcohol as core liver care.


10. China CDC: Mid-Autumn/National Day travel tips for norovirus, respiratory, and mosquito-borne risks; HFMD season high (Public health)

Summary:

On Sep 23, 2026, China CDC issued Mid-Autumn Festival / National Day health guidance (CCTV and others): with linked holidays and heavy travel, prioritize prevention of norovirus and other foodborne illness; influenza and COVID-like respiratory infections; dengue, chikungunya, and other mosquito-borne diseases; plus mpox, severe fever with thrombocytopenia syndrome, and avian influenza. Same-day People’s Daily / Xinhua tips stressed hand-foot-and-mouth disease (HFMD) season: wash hands ≥20 seconds with soap and running water, ventilate and disinfect, avoid crowded indoor venues, and note EV71 vaccine does not replace hygiene. At a National Health Commission autumnal equinox briefing, CDC researcher Peng Zhibin underscored that HFMD and norovirus can reinfect; guard “entry, breathing, and health” gates, and vaccinate high-risk groups against flu early.

Links:

Commentary:

Keep the holiday checklist concrete: no raw water, cook seafood thoroughly, wash hands, use mosquito protection, and get flu shots if high-risk; keep febrile/rash/diarrheal kids home from school.


V. Evidence & Clarification

11. Molecular Systems Biology: in vitro, everyday compounds such as caffeine reshape how sweeteners hit gut bacteria (Evidence clarification)

Summary:

Blasche, Periwal, Patil and colleagues at the MRC Toxicology Unit (Cambridge) systematically tested 39 commercial low-calorie sweeteners against 25 human gut bacterial strains in Molecular Systems Biology (DOI: 10.1038/s44320-026-00225-6; Bioengineer.org Sep 23, 2026), then remapped responses when sweeteners were combined with co-consumed compounds including advantame, caffeine, vanillin, and the antidepressant duloxetine. Sweetener–microbe effects depended strongly on companion xenobiotics—far more complex than “sweetener X always harms the gut.” This is in vitro work and does not prove identical human effects or convict/exonerate any single sweetener.

Links:

Commentary:

Do not treat a petri-dish network as a mandate to quit all non-nutritive sweeteners; prioritize cutting sugary drinks, and judge sweeteners against your overall diet and metabolic goals—not a single lab headline.


Today's Summary

  • From a large UPF dose–response synthesis to a tiny depression pilot, “fewer packages, more cooking” is actionable—while association still is not causation.
  • Post-MI multi-pattern diet quality plus midlife creatine and older-adult resistance findings argue for whole-diet secondary prevention and multidomain training outcomes, not scale weight alone.
  • Lifestyle therapy and CBT-I strengthen the case for putting eat–move–sleep on the formal mood and insomnia menu without replacing acute psychiatric care.
  • China’s community liver baseline and holiday CDC guidance pair metabolic liver risk with low-cost travel levers: hand hygiene, food safety, mosquito control, and vaccines.

Daily Framing:

Today in the sport/health/nutrition cycle was a “de-UPF × function-first training × pre-holiday protection” calibration day—new work mostly quantified risk and intervention feasibility, while practical levers remain less packaging, keep lifting and track function, prefer CBT-I for chronic insomnia, and travel with handwashing, mosquito protection, and timely shots.


This digest is compiled from real-time search results and is for reference only.

MORE FROM SPORTS, HEALTH & NUTRITION

Sep 24, 2026

Sep 24, 2026 · Sports, Health & Nutrition Daily Digest

A roundup of sports, fitness, wellness, and nutrition news for Sep 24, 2026, with summaries, links, and commentary.
Sep 22, 2026

Sep 22, 2026 · Sports, Health & Nutrition Daily Digest

A digest of sports fitness, wellness, and nutrition developments compiled for Sep 22, 2026, with summaries, links, and commentary.
Sep 20, 2026

Sep 20, 2026 · Sports, Health & Nutrition Daily Digest

A digest of sports fitness, wellness, and nutrition developments compiled for Sep 20, 2026, with summaries, links, and commentary.